Page 1 | Search Results | Journal of Human Immunity

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Human Herpesvirus 6 (HHV-6) Infection Impairs T Cell Development in Children with Congenital Athymia Who Have Received Allogeneic Processed Thymus Tissue–agdc (RETHYMIC)

Jack Ringel, Guglielmo Venturi, Elizabeth A. McCarthy, Geoffrey Hall, Cynthia Zhou, Tarin Bigley, John Sleasman

J Hum Immun (2026) 2 (CIS2026): eCIS2026abstract.12.

https://doi.org/10.70962/CIS2026abstract.12

Published: 01 May 2026

View article titled, Human Herpesvirus 6 (HHV-6) Infection Impairs T Cell Development in Children with Congenital Athymia Who Have Received Allogeneic Processed Thymus Tissue–agdc (RETHYMIC)

Includes: Supplementary data

Journal Articles

Dominant-Negative FOXN1 Mutations: Clinical Variability and Omenn Syndrome Management in an International Cohort of 7 Families

Paola Suhet, Evan Potts, Ezgi Nur Alper, Philip Mendez, Serena Shaffren, Emily Ammon, Marita Bosticardo, Christian Wysocki, Nicolai Von Oers, John Sleasman, Marco Yamazaki-Nakashimada, Safa Baris, Svetlana Sharapova, Luigi Notarangelo, Austen Worth, Alexandra Kreins, Jolan Walter

J Hum Immun (2026) 2 (CIS2026): eCIS2026abstract.53.

https://doi.org/10.70962/CIS2026abstract.53

Published: 01 May 2026

View article titled, Dominant-Negative FOXN1 Mutations: Clinical Variability and Omenn Syndrome Management in an International Cohort of 7 Families

Journal Articles

Clinical Variance in an International Cohort of Families with Dominant-Negative FOXN1 Mutations

Evan Potts, Ezgi Nur Alper, Philip Mendez, Serena Shaffren, Paola Suhet, Emily Ammon, Marita Bosticardo, Christian Wysocki, Nicolai Van Oers, John Sleasman, Marco Yamazaki-Nakashimada, Safa Baris, Svetlana Sharapova, Luigi Notarangelo, Austen Worth, Alexandra Kreins, Jolan Walter

J Hum Immun (2025) 1 (LASID2025): eLASID2025abstract.10.

https://doi.org/10.70962/LASID2025abstract.10

Published: 22 December 2025

View article titled, Clinical Variance in an International Cohort of Families with Dominant-Negative FOXN1 Mutations

Journal Articles

Two- to Six-Year Clinical Outcomes Prior to Treatment with Cultured Thymus Tissue Implantation in Children with Congenital Athymia

Benjamin Stewart-Bates, Michael Phillips, Elizabeth McCarthy, Samantha Cresoe-Ortiz, Guglielmo Venturi, Geoffrey Hall, Julie Kim-Chang, Paul Martin, John Sleasman

J Hum Immun (2025) 1 (CIS2025): CIS2025abstract.100.

https://doi.org/10.70962/CIS2025abstract.100

Published: 25 April 2025

View article titled, Two- to Six-Year Clinical Outcomes Prior to Treatment with Cultured Thymus Tissue Implantation in Children with Congenital Athymia

Journal Articles

A Family with a Novel Dominant Negative FOXN1 Heterozygous Variant of Uncertain Significance: A Case Report and Review of the Literature on the Clinical Course

Serena Shaffren, Phil Mendez, David Potts, Monica Hajirawala, Panida Sriaroon, Constance Bindernagel, Kranthi Nomula, Svetlana Sharapova, John Sleasman, Jolan Walter

J Hum Immun (2025) 1 (CIS2025): CIS2025abstract.137.

https://doi.org/10.70962/CIS2025abstract.137

Published: 25 April 2025

View article titled, A Family with a Novel Dominant Negative FOXN1 Heterozygous Variant of Uncertain Significance: A Case Report and Review of the Literature on the Clinical Course

Journal Articles

Congenital Athymia Patient Registry: Patients Treated with Allogeneic Processed Thymus Tissue-agdc Post-FDA Approval

John Sleasman, Elizabeth McCarthy, Alexander Solyom

J Hum Immun (2025) 1 (CIS2025): CIS2025abstract.170.

https://doi.org/10.70962/CIS2025abstract.170

Published: 25 April 2025

View article titled, Congenital Athymia Patient Registry: Patients Treated with Allogeneic Processed Thymus Tissue-agdc Post-FDA Approval

Update search

NARROW

Format

Journal

Article Type

Date

Human Herpesvirus 6 (HHV-6) Infection Impairs T Cell Development in Children with Congenital Athymia Who Have Received Allogeneic Processed Thymus Tissue–agdc (RETHYMIC)

Dominant-Negative FOXN1 Mutations: Clinical Variability and Omenn Syndrome Management in an International Cohort of 7 Families

Clinical Variance in an International Cohort of Families with Dominant-Negative FOXN1 Mutations

Two- to Six-Year Clinical Outcomes Prior to Treatment with Cultured Thymus Tissue Implantation in Children with Congenital Athymia

A Family with a Novel Dominant Negative FOXN1 Heterozygous Variant of Uncertain Significance: A Case Report and Review of the Literature on the Clinical Course

Congenital Athymia Patient Registry: Patients Treated with Allogeneic Processed Thymus Tissue-agdc Post-FDA Approval

Email alerts